Redox Biology and Medicine Training Program

氧化还原生物学与医学培训计划

基本信息

项目摘要

Project Summary This proposal seeks funding for an NRSA Institutional Predoctoral Training Grant from the Systems and Integrative Biology Program of the National Institute for General Medical Sciences. This grant will support predoctoral training in Redox Biology and Medicine (RBM) leading to a Ph.D. degree at Wake Forest University. The RBM Training Program is a multi-disciplinary, multi-departmental program that has as its goal the training of researchers working at the interface of biomedical sciences, biology, chemistry and physics to communicate and work across disciplines to delve into the specialized chemistry of oxidation and reduction reactions underlying the pathophysiology of many diseases. The 34 members of the RBM training faculty are diverse and highly collaborative, and include faculty from Biochemistry, Cancer Biology, Biomedical Engineering, Internal Medicine, Microbiology and Immunology, Chemistry, Biology, and Physics. Seven physician or veterinarian scientists (with MD, MD/PhD or DVM/PhD degrees) are also among the training faculty, encouraging translational science. Participating faculty represent a balance of career stages, including Assistant (10), Associate (11) and full Professors (13). Major scientific themes of the RBM Training Program include the overlapping areas of (i) oxidative modifications regulating metabolism and signal transduction pathways, (ii) redox regulation of nucleic acid metabolism and cell cycle, (iii) reactive nitrogen species biochemistry and biophysics relating to human health, and (iv) redox-linked mechanisms of disease initiation, progression and treatment. The RBM training program has a flexible curriculum built around a common core of required courses (Fundamentals of Redox Biology and Medicine, MCB 715; Omics Data: Generation, Analysis & Exploration, CABI 740; and at least one technology-specific minicourse or workshop), electives, as well as the discipline- specific courses to meet the requirements of the Ph.D. programs of the trainees. Students in the program are trained in such areas as chemical biology, omics (proteomics, lipidomics, metabolomics), biomedical engineering, enzymology, animal models of disease, mitochondrial biology and computational biology / bioinformatics as fits best to the research area of the individual and their Individual Development Plan. The training program takes advantage of the activities driven by the Center for Redox Biology and Medicine in coordination with other basic research and clinical centers at the institution, including a well-developed system of interdisciplinary seminars and retreats to promote interaction among members of the program. Students participate in trainee-focused Chalk Talks which foster development in the cross-discipline communication skills so critical to the multi-disciplinary research in this field. We also offer specific training in skills for a wide variety of potential careers for our Ph.D. graduates, including careers in academia, biotechnology and pharmaceutical industries, intellectual property, and science communication and policy. The guiding principles of Diversity, Equity, and Inclusion as well as anti-racism activities are at the core of our program and present at all levels of organization (students, mentors, Executive Committee, and activities).
项目摘要 该提案为系统和 国家一般医学科学研究所的综合生物学计划。这笔赠款将支持 氧化还原生物学和医学(RBM)培训的培训,导致博士学位。维克森林大学的学位。 RBM培训计划是一个多学科的多部门计划,其目标是培训 在生物医学,生物学,化学和物理学界面上工作的研究人员进行交流 并跨学科工作,以深入研究氧化和还原反应的专门化学 许多疾病的病理生理基础。 RBM培训学院的34名成员是多样的 高度协作,包括来自生物化学,癌症生物学,生物医学工程,内部的教师 医学,微生物学和免疫学,化学,生物学和物理学。七名医生或兽医 科学家(MD,MD/PhD或DVM/PhD学位)也是培训教师 翻译科学。参加教师代表了职业阶段的平衡,包括助手(10), (11)和完整教授(13)。 RBM培训计划的主要科学主题包括 (i)调节代谢和信号转导途径的氧化修饰的重叠区域,(ii) 氧化还原的核酸代谢和细胞周期的调节,(iii)反应性氮物种生物化学和 与人类健康有关的生物物理学以及(iv)疾病起步,进展和 治疗。 RBM培训计划具有灵活的课程,围绕着所需课程的通用核心建立 (氧化还原生物学和医学的基础,MCB 715; OMICS数据:生成,分析与探索, CABI 740;至少一个技术特定的小型或讲习班),选修课以及学科 - 特定课程满足博士学位的要求。学员的计划。该计划中的学生是 在化学生物学,奥理学(蛋白质组学,脂质组学,代谢组学),生物医学培训 工程,酶学,疾病动物模型,线粒体生物学和计算生物学 / 生物信息学最适合个人的研究领域及其个人发展计划。这 培训计划利用了由氧化还原生物学和医学中心驱动的活动 与机构的其他基础研究和临床中心的协调,包括一个发达的系统 跨学科研讨会和务虚会,以促进该计划成员之间的互动。学生 参加以学员为中心的粉笔谈话,以促进跨学科沟通技巧发展 对于该领域的多学科研究至关重要。我们还提供各种技能的特定培训 我们博士的潜在职业毕业生,包括学术界,生物技术和药物的职业 行业,知识产权以及科学传播和政策。多样性的指导原则, 公平,包容性以及反种族主义活动是我们计划的核心,并在各个层面上呈现 组织(学生,导师,执行委员会和活动)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Cristina Maria Furdui其他文献

Cristina Maria Furdui的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Cristina Maria Furdui', 18)}}的其他基金

Overcoming racial health disparities in lung cancer through innovative mechanism-based therapeutic strategies
通过基于机制的创新治疗策略克服肺癌的种族健康差异
  • 批准号:
    10660294
  • 财政年份:
    2023
  • 资助金额:
    $ 21.22万
  • 项目类别:
Redox Biology and Medicine Training Program
氧化还原生物学与医学培训计划
  • 批准号:
    10439794
  • 财政年份:
    2018
  • 资助金额:
    $ 21.22万
  • 项目类别:
Redox Biology and Medicine Training Program
氧化还原生物学与医学培训计划
  • 批准号:
    10200839
  • 财政年份:
    2018
  • 资助金额:
    $ 21.22万
  • 项目类别:
Model-based Prediction of Redox-Modulated Responses to Cancer Treatments
基于模型的氧化还原调节对癌症治疗反应的预测
  • 批准号:
    9769699
  • 财政年份:
    2017
  • 资助金额:
    $ 21.22万
  • 项目类别:
New Oxidation-Sensing Probes to Evaluate Mitochondrial Dysfunction in Lung Injury
用于评估肺损伤中线粒体功能障碍的新型氧化传感探针
  • 批准号:
    9513774
  • 财政年份:
    2017
  • 资助金额:
    $ 21.22万
  • 项目类别:
Model-based Prediction of Redox-Modulated Responses to Cancer Treatments
基于模型的氧化还原调节对癌症治疗反应的预测
  • 批准号:
    10247074
  • 财政年份:
    2017
  • 资助金额:
    $ 21.22万
  • 项目类别:
New Oxidation-Sensing Probes to Evaluate Mitochondrial Dysfunction in Lung Injury
用于评估肺损伤中线粒体功能障碍的新型氧化传感探针
  • 批准号:
    8927844
  • 财政年份:
    2015
  • 资助金额:
    $ 21.22万
  • 项目类别:
2014 Thiol-based Redox Regulation & Signaling GRC and GRS
2014年硫醇氧化还原法规
  • 批准号:
    8718428
  • 财政年份:
    2014
  • 资助金额:
    $ 21.22万
  • 项目类别:
New Reagents for Tracking Protein Oxidation in Cells by MS and Imaging Methods
通过质谱和成像方法追踪细胞中蛋白质氧化的新试剂
  • 批准号:
    8721898
  • 财政年份:
    2013
  • 资助金额:
    $ 21.22万
  • 项目类别:
New Reagents for Tracking Protein Oxidation in Cells by MS and Imaging Methods
通过质谱和成像方法追踪细胞中蛋白质氧化的新试剂
  • 批准号:
    8547235
  • 财政年份:
    2013
  • 资助金额:
    $ 21.22万
  • 项目类别:

相似国自然基金

基于医保战略性购买的国家药品价格谈判政策因果效应、长效机制及优化策略研究
  • 批准号:
    72374167
  • 批准年份:
    2023
  • 资助金额:
    40 万元
  • 项目类别:
    面上项目
药品网上零售即时配送的时空协同优化方法研究
  • 批准号:
    72371044
  • 批准年份:
    2023
  • 资助金额:
    41 万元
  • 项目类别:
    面上项目
天然水体中药品和个人护理品间接光降解产物预测模型的构建和应用
  • 批准号:
    42307496
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
复杂网络视角下互联网药品销售安全风险识别、度量及协同治理研究
  • 批准号:
    72304280
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
国家药品带量采购政策实施效果评价及影响因素分析研究
  • 批准号:
    72304006
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

2021 Mitochondria in Health and Disease Gordon Research Conference
2021 年线粒体健康与疾病戈登研究会议
  • 批准号:
    10236763
  • 财政年份:
    2023
  • 资助金额:
    $ 21.22万
  • 项目类别:
Physiology of Lifespan Extension and Metabolic Hormesis with Riboflavin Depletion
核黄素消耗延长寿命和代谢兴奋作用的生理学
  • 批准号:
    10663638
  • 财政年份:
    2023
  • 资助金额:
    $ 21.22万
  • 项目类别:
Targeting metabolic dependencies in ZFTA-RELA fusion childhood ependymomas
针对 ZFTA-RELA 融合儿童室管膜瘤的代谢依赖性
  • 批准号:
    10655158
  • 财政年份:
    2023
  • 资助金额:
    $ 21.22万
  • 项目类别:
Center of Biomedical Research Excellence in CNS Metabolism
中枢神经系统代谢生物医学卓越研究中心
  • 批准号:
    10557542
  • 财政年份:
    2023
  • 资助金额:
    $ 21.22万
  • 项目类别:
Endothelial Metabolic Reprogramming by Interferon-gamma in Coronary Artery Disease
干扰素γ在冠状动脉疾病中的内皮代谢重编程
  • 批准号:
    10662850
  • 财政年份:
    2023
  • 资助金额:
    $ 21.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了